Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “therapy”

782 pharma patents match "therapy" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 782
Index total 30,257
Page 17 / 33

Quick answer

This filtered view shows 782 pharmaceutical patents matching "therapy" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

782 results for “therapy” · 30,257 patents in full index Clear search

  1. US 10471142

    Combination therapy using immunoglobulin and C1-Inhibitor

    THE GOVERNMENT OF THE UNITED STATES OF AMERICA · Granted Nov 12, 2019 · Expires Nov 7, 2039

    granted
  2. US 10463734

    Nanoparticle therapy in cancer

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 5, 2019 · Expires Oct 31, 2039

    granted
  3. US 10463697

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Nov 5, 2019 · Expires Oct 31, 2039

    granted
  4. US 10449232

    Puma protein expression vector and use thereof in gene therapy

    The Regents of the University of California · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted
  5. US 10451610

    Prediction of response to PARP inhibitors and combinational therapy targeting C-MET and PARP1

    The Board of Regents of the University of Texas System · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted
  6. US 10441645

    MSLN targeting DNA vaccine for cancer immunotherapy

    Vaximm AG · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted
  7. US 10435461

    Therapy for filovirus infection

    The Government of the United States, as represented by the Secretary of the Army · Granted Oct 8, 2019 · Expires Oct 3, 2039

    granted
  8. US 10426797

    Compositions and methods for treating cancer with anti-CD33 immunotherapy

    United State of America, As Represented by the Secretary, Dept. of Health and Human Services · Granted Oct 1, 2019 · Expires Sep 26, 2039

    granted
  9. US 10426786

    Mitigation of epileptic seizures by combination therapy using benzodiazepines and neurosteroids

    The Regents of the University of California · Granted Oct 1, 2019 · Expires Sep 26, 2039

    granted
  10. US 10421963

    Oligonucleotide therapy for leber congenital amaurosis

    ProQR Therapeutics II B.V. · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted
  11. US 10420799

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted
  12. US 10406177

    Modified cells and methods of therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted
  13. US 10406169

    Methods of monitoring estriol therapy

    The Regents of the University of California · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted
  14. US 10407488

    Therapy for treatment or prevention of conditions associated with bleeding or hypocoagulation

    The Regents of the University of California · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted
  15. US 10398734

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Sep 3, 2019 · Expires Aug 29, 2039

    granted
  16. US 10392439

    Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R inhibitor

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 27, 2019 · Expires Aug 22, 2039

    granted
  17. US 10385395

    Diagnostic tools for response to 6-thiopurine therapy

    The Regents of the University of California · Granted Aug 20, 2019 · Expires Aug 15, 2039

    granted
  18. US 10369158

    Pharmaceutical packaging for estriol therapy

    The Regents of the University of California · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  19. US 10369173

    Optimized methods for generation of cardiac stem cells from cardiac tissue and their use in cardiac therapy

    Capricor, Inc. · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  20. US 10369141

    Methods of improving cell-based therapy

    The Regents of the University of California · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  21. US 10363273

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted
  22. US 10357553

    Compositions and methods for combination therapy with dengue virus and dendritic cells

    PrimeVax Immuno-Oncology · Granted Jul 23, 2019 · Expires Jul 18, 2039

    granted
  23. US 10342815

    GLA monotherapy for use in cancer treatment

    IMMUNE DESIGN CORP. · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted
  24. US 10335382

    Use of hydrogen sulfide synthesis inhibitors for cancer therapy

    The Board of Regents of the University of Texas System · Granted Jul 2, 2019 · Expires Jun 27, 2039

    granted